ZA202000461B - Composition for use in the prevention and treatment of pathologies of the cardiovascular apparatus - Google Patents

Composition for use in the prevention and treatment of pathologies of the cardiovascular apparatus

Info

Publication number
ZA202000461B
ZA202000461B ZA2020/00461A ZA202000461A ZA202000461B ZA 202000461 B ZA202000461 B ZA 202000461B ZA 2020/00461 A ZA2020/00461 A ZA 2020/00461A ZA 202000461 A ZA202000461 A ZA 202000461A ZA 202000461 B ZA202000461 B ZA 202000461B
Authority
ZA
South Africa
Prior art keywords
pathologies
prevention
treatment
composition
cardiovascular apparatus
Prior art date
Application number
ZA2020/00461A
Inventor
Andrea Lacorte
Germano Tarantino
Elisa Brilli
Original Assignee
Pharmanutra S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmanutra S P A filed Critical Pharmanutra S P A
Publication of ZA202000461B publication Critical patent/ZA202000461B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/15—Inorganic Compounds
    • A23V2250/156—Mineral combination
    • A23V2250/1592—Iron
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/15—Inorganic Compounds
    • A23V2250/156—Mineral combination
    • A23V2250/161—Magnesium
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/70—Vitamins
    • A23V2250/714—Vitamin K
    • A23V2250/7144—Vitamin K2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA2020/00461A 2017-07-26 2020-01-23 Composition for use in the prevention and treatment of pathologies of the cardiovascular apparatus ZA202000461B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT102017000085412A IT201700085412A1 (en) 2017-07-26 2017-07-26 Composition for use in the prevention and treatment of cardiovascular diseases
PCT/IB2018/055586 WO2019021232A1 (en) 2017-07-26 2018-07-26 COMPOSITION FOR THE PROPHYLACTIC AND THERAPEUTIC TREATMENT OF CARDIOVASCULAR DISORDER DISORDERS

Publications (1)

Publication Number Publication Date
ZA202000461B true ZA202000461B (en) 2021-03-31

Family

ID=60451085

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2020/00461A ZA202000461B (en) 2017-07-26 2020-01-23 Composition for use in the prevention and treatment of pathologies of the cardiovascular apparatus

Country Status (19)

Country Link
US (1) US20200206157A1 (en)
EP (1) EP3657963A1 (en)
JP (2) JP2020528888A (en)
KR (1) KR20200032691A (en)
CN (1) CN111031813A (en)
BR (1) BR112020000902B1 (en)
CA (1) CA3070659A1 (en)
CL (1) CL2020000170A1 (en)
CO (1) CO2020000526A2 (en)
EA (1) EA202090069A1 (en)
IL (1) IL272138B2 (en)
IT (1) IT201700085412A1 (en)
JO (1) JOP20200012A1 (en)
MA (1) MA49794A (en)
MX (1) MX2020000806A (en)
PE (1) PE20200794A1 (en)
PH (1) PH12020550031A1 (en)
WO (1) WO2019021232A1 (en)
ZA (1) ZA202000461B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201700089258A1 (en) 2017-08-02 2019-02-02 Pharmanutra S P A Composition for use in the prevention and treatment of iron deficiency
KR20210018423A (en) 2018-06-08 2021-02-17 에피존 파마 인코포레이티드 Methods and compositions for preventing or treating tissue calcification
MX2020013301A (en) 2018-06-08 2021-05-12 Epizon Pharma Inc Methods and compositions for preventing or treating calciphylaxis.
IT201900007311A1 (en) 2019-05-27 2020-11-27 Alesco Srl Process for the preparation of a composition comprising cetylated fatty acids
IT201900007326A1 (en) 2019-05-27 2020-11-27 Alesco Srl Compositions comprising cetylated fatty acids and their use in the treatment of arthritis and joint inflammatory states
CN114748486A (en) * 2022-03-25 2022-07-15 南京盛德生物科技研究院有限公司 A food containing vitamin K2Pharmaceutical composition for improving cardiovascular calcification and preparation method and application thereof
KR20250019094A (en) 2022-05-31 2025-02-07 레지온 시드단마크 Vitamin K2 for the treatment of coronary artery calcification (CAC)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3860849B2 (en) * 1994-04-28 2006-12-20 エーザイ・アール・アンド・ディー・マネジメント株式会社 Anti-arteriosclerotic agent
EP0831728A2 (en) * 1995-06-06 1998-04-01 Campbell Soup Company Mineral supplements for dietetic food
US6361800B1 (en) * 2000-04-13 2002-03-26 Cooper Concepts, Inc. Multi-vitamin and mineral supplement
GB0220182D0 (en) * 2002-08-30 2002-10-09 Cardiovascular Res Inst Maastr Organic compounds
JP4838139B2 (en) * 2003-10-28 2011-12-14 エモリー ユニバーシティー Dialysis fluid and method and system related to dialysis fluid
US20050281888A1 (en) * 2004-06-16 2005-12-22 Chandra Ranjit K Nutritional supplement for infants
WO2006055526A2 (en) * 2004-11-16 2006-05-26 Nu-Tein Co., Inc. Compositions useful to treat ocular neovascular diseases and macular degeneration
CN102861336A (en) * 2005-12-23 2013-01-09 阿贾伊·古普塔 Iron-containing parenteral nutrition composition
CN101374416A (en) * 2006-01-30 2009-02-25 环亚有限公司 Method for reversing, preventing, delaying or stabilizing soft tissue calcification
US20100021573A1 (en) * 2008-07-22 2010-01-28 Michael J Gonzalez Compositions and methods for the prevention of cardiovascular disease
CN102159222B (en) * 2008-12-25 2014-08-06 I.B.E.有限会社 Bioactive agents, drugs, cosmetics, preservatives, and growth promoters for plants and animals
PH12013502396A1 (en) * 2011-05-20 2019-07-17 Friesland Brands Bv Composition comprising vitamin k2
ITMI20121350A1 (en) * 2012-07-31 2014-02-01 Alesco Srl IRON SOLID COMPOSITION FOR USE IN IRON DEFICIENCY CONDITIONS.
EP2886129A1 (en) * 2013-12-20 2015-06-24 VitaK B.V. Prevention and counteraction of diet-induced thrombosis risk
EP3258924A2 (en) * 2015-02-20 2017-12-27 VitaK B.V. Vitamin k and capillary function
US11344575B2 (en) * 2016-08-15 2022-05-31 Summit Innovation Labs, LLC Vascular calcification prevention and treatment

Also Published As

Publication number Publication date
MX2020000806A (en) 2020-08-17
CN111031813A (en) 2020-04-17
CO2020000526A2 (en) 2020-02-18
IL272138B1 (en) 2023-05-01
EP3657963A1 (en) 2020-06-03
WO2019021232A1 (en) 2019-01-31
MA49794A (en) 2020-06-03
IT201700085412A1 (en) 2019-01-26
KR20200032691A (en) 2020-03-26
PH12020550031A1 (en) 2021-02-08
BR112020000902A2 (en) 2020-07-21
IL272138A (en) 2020-03-31
PE20200794A1 (en) 2020-08-10
JOP20200012A1 (en) 2020-01-26
CL2020000170A1 (en) 2020-10-30
IL272138B2 (en) 2023-09-01
JP2023090869A (en) 2023-06-29
US20200206157A1 (en) 2020-07-02
BR112020000902B1 (en) 2024-03-12
CA3070659A1 (en) 2019-01-31
EA202090069A1 (en) 2020-04-10
JP2020528888A (en) 2020-10-01

Similar Documents

Publication Publication Date Title
IL268406A (en) Compositions and methods for the treatment of hemoglobinopathies
IL272138A (en) Composition for use in the prevention and treatment of pathologies of the cardiovascular apparatus
IL260257A (en) Compositions and methods for the treatment of hemoglobinopathies
IL290150A (en) Compositions and methods for the treatment of chronic pain
IL275626A (en) Surface treatment compositions and methods
LT3481846T (en) 11-substituted 24-hydroxysterols for use in the treatment of nmda related conditions
IL275182A (en) Compositions and methods for the treatment of metabolic conditions
IL272121A (en) Composition and methods for the treatment of myopia
IL272414A (en) Use of gaboxadol in the treatment of diabetes and related conditions
SMT202500469T1 (en) Pharmaceutical combination comprising ponesimod and its use in the treatment of multiple sclerosis
SG11202100675YA (en) Surface treatment compositions and methods
SI4101454T1 (en) Compositions for use in the treatment of hypertension
GB2581876B (en) Compositions for use in the treatment of endometrial disorder
ZA201905402B (en) Compounds and their use in the treatment of schistosomiasis
IL271758A (en) Statin compositions and methods for use in treating synucleinopathies
SMT202200151T1 (en) Compositions and methods for use in the treatment of homocystinuria
IL273863B1 (en) Device for use in the treatment of hemorrhoids
IL257452B (en) Methods and compositions for the treatment of cytoplasmic glycogen storage disorders
SG11202000612TA (en) Methods and compositions for the treatment of melanoma
ZA202006886B (en) R-fadrozole for use in the treatment of aldostonerism
GB2524474B (en) Composition and use of lactobacillus reuteri GMNL-89 in treating type 2 diabetes
LT3548006T (en) Composition for use in the treatment of intestinal alterations
PT3191112T (en) Dipeptidyl ketoamide compounds and their use for the treatment and/or prevention of fat accumulation
IL271564A (en) Compositions for the prevention and treatment of acute renal injury
GB201710491D0 (en) Composition and methods of treatment